What Researchers Did
Researchers retrospectively reviewed outcomes of hyperbaric oxygen therapy (HBOT) for symptomatic brain radionecrosis in 13 patients at a single institution between 2008 and 2018.
What They Found
Of the 13 patients, 12 (92%) experienced clinical improvement, with a median time to symptom improvement of 33 days. Among eight patients with evaluable MRI, four showed radiological improvement and four had stable necrosis. Seven patients (54%) reported side effects, primarily otologic.
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a promising treatment option for Canadian patients experiencing symptomatic brain radionecrosis after radiation. This therapy could lead to significant clinical improvement and potentially reduce the need for steroids.
Canadian Relevance
This study, published in the Canadian Journal of Neurological Sciences, directly addresses a relevant clinical issue for Canadian healthcare providers and patients.
Study Limitations
Key limitations include the small sample size of 13 patients and the retrospective, single-institution design.